Related Experiment Video
Updated: May 7, 2025

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
Increased serum galectin-3 level is associated with endothelial dysfunction and cardiovascular events in patients
Hui-Sheng Wang1, Bang-Gee Hsu2, Ji-Hung Wang1,3,4
1Division of Cardiology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Insights
Higher galectin-3 (Gal-3) levels are linked to poor vascular reactivity and increased cardiovascular events in hypertension patients. This suggests Gal-3 may play a role in hypertension-induced endothelial dysfunction.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Inflammation Research
Background:
- Endothelial dysfunction is a precursor to cardiovascular complications.
- Galectin-3 (Gal-3) is implicated in inflammatory cardiac diseases.
- The specific role of Gal-3 in hypertension-related endothelial dysfunction requires clarification.
Purpose of the Study:
- To investigate the association between serum galectin-3 (Gal-3) levels and endothelial dysfunction in hypertensive patients.
- To evaluate the relationship between Gal-3 levels and long-term cardiovascular outcomes in this cohort.
Main Methods:
- 120 hypertensive patients were enrolled, with 7-year cardiovascular outcome monitoring.
- Serum Gal-3 levels were quantified using enzyme-linked immunosorbent assay.
- Vascular reactivity index (VRI) was assessed via digital thermal monitoring.
Main Results:
- Poor vascular reactivity was observed in 12 patients, intermediate in 57, and good in 51.
- Factors associated with poor endothelial dysfunction included older age, elevated cholesterol and LDL, lower eGFR, and higher Gal-3 levels.
- Higher Gal-3 levels correlated with lower VRI and were linked to increased cardiovascular events over 7 years.
Conclusions:
- Elevated serum Gal-3 levels are associated with endothelial dysfunction in hypertensive individuals.
- Higher Gal-3 levels predict adverse cardiovascular events in patients with hypertension.
- Galectin-3 may be a significant factor in the pathophysiology of hypertension-induced endothelial dysfunction.
Background:
Endothelial dysfunction can lead to various harmful cardiovascular complications. The importance of galectin-3 (Gal-3) has been proposed in some cardiac diseases related to chronic inflammation. However, its role in hypertension-induced endothelial dysfunction remains unclear.
Methods:
We enrolled 120 patients with hypertension, assessed their baseline characteristics, and monitored their 7-year cardiovascular outcomes. We performed an enzyme-linked immunosorbent assay to measure serum Gal-3 levels. The vascular reactivity index (VRI) was examined by digital thermal monitoring. Patients with VRI <1.0, 1.0 to <2.0, and ≥2.0 were defined as having poor, intermediate, and good vascular reactivity, respectively.
Results:
Among the recruited patients, 12 had poor vascular reactivity, 57 had intermediate vascular reactivity, and 51 had good vascular reactivity. Older age, higher total cholesterol levels, higher low-density lipoprotein cholesterol levels, lower estimated glomerular filtration rate, and higher Gal-3 levels were associated with poor endothelial dysfunction. Multivariate linear regression analysis showed that age and Gal-3 levels were correlated with VRI. During the 7-year follow-up period, patients with higher Gal-3 levels had more cardiovascular events.
Conclusions:
Higher Gal-3 levels are associated with endothelial dysfunction and unfavorable cardiovascular outcomes in patients with hypertension, suggesting its potential role in the hypertension-induced endothelial dysfunction.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension and Regulation of Blood Pressure
Proteoglycans

